Siamab Therapeutics, Inc.

Biotechnology company · Newton, Massachusetts, United States

Siamab Therapeutics, Inc. is a biotechnology company headquartered in Newton, Massachusetts, United States. It has reported private securities offerings to the US SEC, most recently $664,501 sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Siamab Therapeutics at a glance

Typebiotechnology company

HeadquartersNewton, Massachusetts, United States

SEC CIK1351615

What does Siamab Therapeutics do?

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $664,501 sold (2018).

Frequently asked questions about Siamab Therapeutics

Where is Siamab Therapeutics headquartered?

Siamab Therapeutics, Inc. is headquartered in Newton, Massachusetts, United States.

What does Siamab Therapeutics do?

Siamab Therapeutics, Inc. is a biotechnology company.

Similar companies

Lumicell, Inc.Newton, Massachusetts, United States
Acumen Pharmaceuticals, Inc.Newton, Massachusetts, United States
Courage Therapeutics, Inc.Newton, Massachusetts, United States
Extend Biosciences IncNewton, Massachusetts, United States
Normatec Industries, LPNewton, Massachusetts, United States
TheraNano LLCNewton, Massachusetts, United States
Auron Therapeutics, Inc.Newton, Massachusetts, United States
Diceros Therapeutics, Inc.Newton, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences